Gs Investments Inc. raised its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 56.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,404 shares of the healthcare conglomerate’s stock after buying an additional 3,039 shares during the period. UnitedHealth Group comprises approximately 1.6% of Gs Investments Inc.’s portfolio, making the stock its 27th largest position. Gs Investments Inc.’s holdings in UnitedHealth Group were worth $2,236,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wellington Shields Capital Management LLC raised its stake in shares of UnitedHealth Group by 12.4% during the third quarter. Wellington Shields Capital Management LLC now owns 10,882 shares of the healthcare conglomerate’s stock valued at $2,895,000 after acquiring an additional 1,200 shares during the last quarter. Heritage Investors Management Corp raised its stake in shares of UnitedHealth Group by 7.6% during the third quarter. Heritage Investors Management Corp now owns 42,928 shares of the healthcare conglomerate’s stock valued at $11,421,000 after acquiring an additional 3,038 shares during the last quarter. Gryphon Financial Partners LLC raised its stake in shares of UnitedHealth Group by 236.2% during the third quarter. Gryphon Financial Partners LLC now owns 2,451 shares of the healthcare conglomerate’s stock valued at $652,000 after acquiring an additional 1,722 shares during the last quarter. Unigestion Holding SA raised its stake in shares of UnitedHealth Group by 21.0% during the third quarter. Unigestion Holding SA now owns 18,080 shares of the healthcare conglomerate’s stock valued at $4,810,000 after acquiring an additional 3,143 shares during the last quarter. Finally, Global Financial Private Capital LLC raised its stake in shares of UnitedHealth Group by 17.0% during the third quarter. Global Financial Private Capital LLC now owns 20,604 shares of the healthcare conglomerate’s stock valued at $5,482,000 after acquiring an additional 2,992 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

In related news, CEO Steven H. Nelson sold 8,142 shares of the stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $265.00, for a total value of $2,157,630.00. Following the completion of the transaction, the chief executive officer now directly owns 22,496 shares of the company’s stock, valued at $5,961,440. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Over the last three months, insiders sold 69,731 shares of company stock valued at $18,584,675. 0.87% of the stock is owned by insiders.

Several equities analysts have recently commented on the stock. BMO Capital Markets upped their price objective on shares of UnitedHealth Group to $310.00 and gave the company an “outperform” rating in a research note on Thursday, October 18th. Argus upped their price objective on shares of UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday, October 18th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $276.00 to $295.00 and gave the company an “outperform” rating in a research note on Wednesday, October 17th. Royal Bank of Canada upped their price objective on shares of UnitedHealth Group to $308.00 and gave the company an “outperform” rating in a research note on Wednesday, October 17th. Finally, Piper Jaffray Companies upped their price objective on shares of UnitedHealth Group to $300.00 and gave the company an “overweight” rating in a research note on Wednesday, October 17th. One research analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $289.41.

UNH stock opened at $271.11 on Monday. UnitedHealth Group Inc has a 1 year low of $208.48 and a 1 year high of $278.00. The stock has a market capitalization of $260.82 billion, a P/E ratio of 26.92, a P/E/G ratio of 1.56 and a beta of 0.78. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company had revenue of $56.56 billion during the quarter, compared to the consensus estimate of $56.34 billion. During the same period in the prior year, the firm earned $2.66 earnings per share. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Inc will post 12.81 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Friday, November 30th. UnitedHealth Group’s payout ratio is currently 35.75%.

WARNING: “Gs Investments Inc. Has $2.24 Million Holdings in UnitedHealth Group Inc (UNH)” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/11/19/gs-investments-inc-has-2-24-million-holdings-in-unitedhealth-group-inc-unh.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: How Does the Quiet Period Work?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.